Literature DB >> 22660257

[Antidepressant drugs : a reasonable therapy for pruritus?].

U Raap1, A Kapp, U Darsow.   

Abstract

Pruritus represents one of the most bothersome symptoms of skin and internal diseases, and can also occur without an underlying detectable cause. It is well known that chronic pruritus seriously affects the quality of life in patients. The management of pruritus is challenging, especially if the underlying cause is not identifiable. Besides therapy with increased dosage of non-sedating H1-antihistamines, which is often not successful in severe pruritus, tri- or tetracyclic antidepressants and selective serotonin-reuptake inhibitors are recommended for therapy, as discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22660257     DOI: 10.1007/s00105-011-2320-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  25 in total

1.  Selective serotonin reuptake inhibitors are effective in the treatment of polycythemia vera-associated pruritus.

Authors:  Ayalew Tefferi; Rafael Fonseca
Journal:  Blood       Date:  2002-04-01       Impact factor: 22.113

Review 2.  [Diagnostic and therapeutic procedures in chronic pruritus].

Authors:  Sonja Ständer; Markus Streit; Ulf Darsow; Volker Niemeier; Maria Vogelgsang; Hartmut Ständer; Uwe Gieler; Harald Gollnick; Dieter Metze; Elke Weisshaar
Journal:  J Dtsch Dermatol Ges       Date:  2006-04       Impact factor: 5.584

3.  Doxepin affects acetylcholine induced cutaneous reactions in atopic eczema.

Authors:  D Groene; P Martus; G Heyer
Journal:  Exp Dermatol       Date:  2001-04       Impact factor: 3.960

4.  Sertraline as a first-line treatment for cholestatic pruritus.

Authors:  Marlyn J Mayo; Iorna Handem; Sandra Saldana; Heidi Jacobe; Yonas Getachew; A John Rush
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

5.  Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial.

Authors:  Zbigniew Zylicz; Malgorzata Krajnik; Adriaan Alistar van Sorge; Massimo Costantini
Journal:  J Pain Symptom Manage       Date:  2003-12       Impact factor: 3.612

6.  Low-dose doxepin for treatment of pruritus in patients on hemodialysis.

Authors:  Fatemeh Pour-Reza-Gholi; Alireza Nasrollahi; Ahmad Firouzan; Ensieh Nasli Esfahani; Farhat Farrokhi
Journal:  Iran J Kidney Dis       Date:  2007-07       Impact factor: 0.892

7.  Relief of pruritus in patients with atopic dermatitis after treatment with topical doxepin cream. The Doxepin Study Group.

Authors:  L A Drake; J D Fallon; A Sober
Journal:  J Am Acad Dermatol       Date:  1994-10       Impact factor: 11.527

8.  Inhibition of histamine-induced pruritus by topical tricyclic antidepressants.

Authors:  J E Bernstein; D H Whitney; K Soltani
Journal:  J Am Acad Dermatol       Date:  1981-11       Impact factor: 11.527

9.  Mirtazapine for reducing nocturnal itch in patients with chronic pruritus: a pilot study.

Authors:  Jennifer L Hundley; Gil Yosipovitch
Journal:  J Am Acad Dermatol       Date:  2004-06       Impact factor: 11.527

10.  Treatment of chronic pruritus with the selective serotonin re-uptake inhibitors paroxetine and fluvoxamine: results of an open-labelled, two-arm proof-of-concept study.

Authors:  Sonja Ständer; Barbara Böckenholt; Funda Schürmeyer-Horst; Carsten Weishaupt; Gereon Heuft; Thomas A Luger; Gudrun Schneider
Journal:  Acta Derm Venereol       Date:  2009       Impact factor: 4.437

View more
  1 in total

Review 1.  Pharmacological interventions for pruritus in adult palliative care patients.

Authors:  Waldemar Siemens; Carola Xander; Joerg J Meerpohl; Sabine Buroh; Gerd Antes; Guido Schwarzer; Gerhild Becker
Journal:  Cochrane Database Syst Rev       Date:  2016-11-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.